Risk and Benefit of Oral Anticoagulants in Atrial Fibrillation

被引：0
|
作者：
Zotova, I. V. [1 ]
Zateyshchikov, D. A. [1 ]
机构：
[1] President RF, FSI Educ Sci Med Ctr, Gen Management Dept, Moscow 121356, Russia
来源：
KARDIOLOGIYA | 2011年 / 51卷 / 10期
关键词：
atrial fibrillation; indirect anticoagulants; thromboembolism; bleeding; risk stratification; CLINICAL CLASSIFICATION SCHEMES; MAJOR BLEEDING COMPLICATIONS; SOLUBLE CD40 LIGAND; WARFARIN THERAPY; STROKE RISK; VENOUS THROMBOEMBOLISM; ARTERIAL EMBOLISM; NATIONAL REGISTRY; PREDICTING STROKE; ISCHEMIC-STROKE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thromboembolism is the main cause of death and disability of patients with atrial fibrillation. Indirect anticoagulants are effective means of primary and secondary prevention of thromboembolic complications. However in a number of patients risk associated with therapy with indirect anticoagulants might exceed potential benefit. The principle problem requiring solution in a patient with atrial fibrillation is individual comparative assessment of risk of development of thromboembolic and hemorrhagic complications. Modern stratification scales which allow solving this problem are considered in this review.
引用
收藏
页码：81 / 91
页数：11
相关论文
共 50 条
  • [31] Oral anticoagulants in older adults with atrial fibrillation
    Bernacki, Gwen M.
    Becker, Richard C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 36 (04) : 403 - 415
  • [32] Adherence to oral anticoagulants in patients with atrial fibrillation
    Grimaldi-Bensouda, Lamiae
    Le Heuzey, Jean-Yves
    Abenhaim, Lucien
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 106 - 106
  • [33] A Review of Oral Anticoagulants in Patients with Atrial Fibrillation
    Greenspon, Arnold J.
    POSTGRADUATE MEDICINE, 2012, 124 (06) : 7 - 16
  • [34] Novel oral anticoagulants and atrial fibrillation in the elderly
    Hanon, Olivier
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2013, 11 : 34 - 40
  • [35] Satisfaction with oral anticoagulants in patients with atrial fibrillation
    Suarez Fernandez, Carmen
    Castilla-Guerra, Luis
    Cantero Hinojosa, Jesus
    Maria Surinach, Josep
    Acosta de Bilbao, Fernando
    Jose Tamarit, Juan
    Diaz Diaz, Jose Luis
    Luis Hernandez, Jose
    Pose, Antonio
    Montero-Perez-Barquero, Manuel
    Roquer, Jaume
    Gallego, Jaime
    Vivancos, Jose
    Maria Mostaza, Jose
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 267 - 274
  • [36] New oral anticoagulants in patients with atrial fibrillation
    Shah, Rahman
    Jamy, Omer
    Matin, Khalid
    LANCET, 2014, 384 (9937): : 23 - 24
  • [37] New Oral Anticoagulants in Nonvalvular Atrial Fibrillation
    Urooj, Fatima
    Kulkarni, Abhishek
    Stapleton, Dwight
    Kaluski, Edo
    CLINICAL CARDIOLOGY, 2016, 39 (02) : 739 - 746
  • [38] Number needed to treat for net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation
    Krittayaphong, Rungroj
    Pumprueg, Satchana
    Yindeengam, Ahthit
    Lip, Gregory Y. H.
    JOURNAL OF ARRHYTHMIA, 2025, 41 (01)
  • [39] Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer: a nationwide cohort study
    Atterman, Adriano
    Friberg, Leif
    Asplund, Kjell
    Engdahl, Johan
    EUROPACE, 2020, 22 (01): : 58 - 65
  • [40] Comparing the risk of dementia in patients with atrial fibrillation taking different oral anticoagulants
    Sung, Sheng-Feng
    Yang, Hsin-Yi
    Tsai, Ching-Fang
    Fang, Chen- Wen
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 139 - 141
12345